
15 March, 2010
Benchmark Biolabs to Attend BIO 2010 International Convention
Since 1996, Benchmark Biolabs has served as the link between the biological discovery and the commercial product. Whether it be cutting edge influenza research in our select agent approved BSL-3 facility, or pioneering plant-derived vaccine development including the world's first licensed product and facility, our experienced staff has provided its numerous multinational biotech and pharmaceutical clients with a full range of scalable services; focused on the validation, development, licensure, and commercialization of their unique technologies.
Benchmark Biolabs is focused on providing the highest quality, most responsive, and most adaptable service to our customers at any point on the path from concept to commercialization. A few examples include, but are far from limited to the following:
- Research and Development
- Assay Development:
- Bioanalytical Testing and Validation
- Genetic Testing Services
- Custom Services
- Reagents
- Clinical Studies
- Biosafety Level-3 Clinical Testing
- Immunogenicity
- Safety and Challenge
- Hyperimmunization for Antibody Production
- Tissue and Immune-Cell Isolation.
- Animal Model Development (Target or Surrogate),
- Serum- and Antibody-Response Assays Proof of Concept
- Efficacy/Immunogenicity (i.e. Minimum Immunizing Dose)
- Specialized Reagent Production (i.e. High Pathogenic Avian Influenza )
- Interference
- Vaccine Safety (Target and Surrogate Animal)
- Field Safety
- Manufacturing (including process development and scale up)
- Fermentation
- Tissue Culture
- Down-Stream Processing
- Adjuvant Development
- Formulation
- Regulatory Compliance
- Expert development of product-licensing plans
- Preparation and maintenance of regulatory submissions
- Regulatory strategies to facilitate product authorization
- Quality Assurance
- Quality Control
If you would like to schedule a meeting with us during the BIO convention (May 3-6) to discuss how our services may be of benefit to your company, please contact:
Dr. Tom Overbay at toverbay@benchmarkbiolabs.com or
Mr. Josh Johnson at jjohnson@benchmarkbiolabs.com
Telephone: (402) 475-8104.
|